Patients who were treated with Xeljanz for rheumatoid arthritis (RA) may be entitled to compensation if they experienced serious side effects and complications that could be related to its use. Attorneys around the country are now evaluating potential Xeljanz lawsuits, and are investigating allegations that Pfizer, Inc. failed to properly warn patients and doctors about its serious risks. Patients who may have been harmed by this drug are being urged to seek legal advice immediately to ensure their rights are protected.
Xeljanz was brought to market by Pfizer in 2012, and is indicated for the treatment of moderate to severe active RA that has not responded to methotrexate. It works by blocking certain enzymes in the body that affect immune system function. Serious side effects that may be associated with Xeljanz include:
In 2013, Pfizer failed to obtain approval for Xeljanz as an RA therapy in Europe because of concerns about serious infections associated with its use. In doing so, European regulators determined that the drug’s benefits did not outweigh its risks.
In October 2015, the U.S. Food & Drug Administration (FDA) turned down a bid by Pfizer to expand the approved uses of Xeljanz to include the treatment of moderate to severe plaque psoriasis. According to Pfizer, the agency has asked that it provide additional safety analyses.
Filing a Xeljanz lawsuit may allow patients allegedly harmed by this drug to obtain compensation for the physical, financial and emotional damages related to their injuries, including:
The families of patients who allegedly died as a result of Xeljanz-related complications may also be able to obtain compensation for wrongful death, funeral expenses, mental anguish, and more.
To prevail against Pfizer, potential Xeljanz plaintiffs must be able to prove that the medication was unsafe, and that the company failed to provide appropriate warning about its potential risks. Pursuing such a case is a complex undertaking, and requires the assistance of product liability attorneys with extensive experience litigating drug injury claims.
The attorneys at Bernstein Liebhard LLP have represented hundreds of people seriously injured by drug side effects and defective medical products. If you are interested in pursuing compensation for alleged Xeljanz complications, our Firm can represent you on a contingency basis, which means that you will not be required to pay any legal fees unless our attorneys obtain a recovery on your behalf. If your case is not successful, you will not be required to remit any fees to the Firm whatsoever.
If you would like to learn more about filing a Xeljanz lawsuit, please call to discuss you case with our legal staff today.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.